* A corporate client of Hybridan LLP.
** Potential means Intention to Float (ITF) or similar announcement has been made.
***Arranged by type of listing and date of announcement.
****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication.
Admissions:
Reveille Resources has admitted to trading on AQSE after successfully raising gross proceeds of £2.0m at a price of 5p per share. Prior to the Fundraise, the Company raised a total of £680k by way of pre-IPO subscriptions. The strategy is focused on identifying and advancing uranium exploration opportunities in assets that have benefited from significant historical expenditure and technical work, but which may not have achieved full value realisation due to geopolitical, technological, financial, or historical factors. Reveille’s initial focus is on two historical uranium deposits in Lombardy, northern Italy.
Delistings:
None
What’s baking in the oven?
It's a little empty
Banquet Buffet****
London Stock Exchange: Main Market and AIM
Alien Metals Limited 0.11p £12.9m (UFO.L)
The minerals exploration and development Company has entered into a conditional agreement with Venari Minerals Ltd, listed on the ASX, to acquire 100% of the fully paid ordinary shares in the capital of Knox Resources Pty Ltd, a wholly owned subsidiary of Venari. Knox is the 100% legal and beneficial owner of the Georgina Basin Iron-Oxide Copper Gold project, comprising a tenement package totaling approximately 2,500 km² located in the Northern Territory, Australia. The Acquisition is subject, inter alia, to the satisfactory completion of due diligence by the Company.
Enwell Energy 12.75p £40.88m (ENWL)
The AIM-quoted oil and gas exploration and production Company updated on its operational activities in Ukraine in respect of its Mekhediviska-Golotvshinska, Svyrydivske and Vasyschevskoye gas and condensate fields and Svystunivsko-Chervonolutskyi exploration licence. The MEX-GOL, SV and VAS production licences have remained suspended and, accordingly, there was no production from those licences in the second quarter, nor at present. At the SC exploration licence area, development planning is continuing, including planning for the drilling of the SC-5 exploration well, and for the installation of new gas processing facilities and other surface infrastructure, as well as assessing the feasibility of an alternative option of a connection to existing gas processing facilities. Additionally, temporary gathering, separation and compression equipment is being installed, which will enable gas and condensate from the SC-4 well to be separated, the gas compressed at site and then trucked to the Company's existing gas processing facilities at its MEX-GOL and SV fields for treatment and sale.
First Class Metals 2.55p £13.79m (FCM.L)
The UK listed Company focused on the discovery of economic metal deposits across its exploration properties in Ontario, Canada, reported the final, cumulative drill results for the Roy drilling programme on the Sunbeam Property. Bonanza-grade gold was confirmed in diamond drill hole SUN26-05 by double Fire Assays, validating the previously reported Photon Assay results. Gold mineralisation was confirmed over approximately 300m of strike, with anomalous to potentially ore-grade gold values, remaining open along strike and at depth. Exploration work continues at the parallel Pettigrew trend, applying the structural model developed at Roy to generate drill targets, while an Exploration Permit application has been submitted for winter drilling on the frozen lake adjacent to Roy.
Forgent 0.01p £4.48m (FORG.L)
The technology-led energy transition Company announced that it has successfully completed the Phase 1 drilling programme at the Company's Peak Hills gold-copper project in Western Australia. The Phase 1 programme was designed to test multiple high-priority targets across the Karalundi, Junction and Curleys prospects. The programme has focused on validation of historic exploration results, extension of known mineralisation, and evaluation of additional mineralised zones across the broader project area, to advance the Company's understanding of the gold-copper potential at Peak Hills. The programme comprised 40 drill holes for a total of approximately 2,680 metres, with drill depths of up to 100 metres. A combination of aircore and reverse circulation drilling techniques was utilised, with RC drilling employed where hard ground conditions prevented effective aircore drilling. 1,587 samples, a combination of 3m composite and single metre samples from the drilling programme, have been submitted to a Perth-based independent laboratory for assay.
Great Western Mining Corporation 3.15p £13.75m (GWMO.L)
The strategic minerals exploration and development Company announced assay results from a machine-cut channel sampling programme at its Defender-Pine Crow in Mineral County, Nevada, USA. Four new machine-cut channels were completed in April 2026 at Defender-Pine Crow returning significant tungsten mineralisation, with the widest intercept Channel C of 27 m (89 ft) @ 0.15% WO3, including 11 m (30 ft) @ 0.25% WO3. There was very low concentrations of potential penalty elements (including Molybdenum) encountered during WO3 processing, while Silver (Ag) mineralisation was found in Channel F across 2 intervals of 2m @ 17.6 g/t Ag and 2m @ 10.1 g/t Ag in the transition between Dunlap Formation limestones and garnet skarn. Additional infill rock chip samples between Defender Mine and the Company's M2 copper resource supports the hypothesis that there is a 2-3 km corridor of tungsten mineralisation. Channel and rock chip sampling results will inform the Company's fully permitted maiden drilling programme, expected to commence in the coming weeks.
Ixico 9.00p £17.79m (IXI.L)
The neuroscience imaging and biomarker analytics Company updates on trading for the current full year to 30 September 2026. Revenues are anticipated to be at least £8.0m, which is ahead of existing market expectations of £7.5m and is a 22% increase on FY 2025 revenues as there is strong trading across an increasingly diverse client base combined with contract extensions. This results from the plan put in place in 2024 and according to Bram Goorden, CEO of IXICO, “We will continue to deliver innovative differentiated scientific products, services and technology that position IXICO at the forefront of neuroscience."
Neoterra Group 2.20p £9.15m (TERA.L)
The African critical minerals exploration and development Company (formerly Altona Rare Earths), updated on operational progress at its Monte Muambe Project. Maelgwyn metallurgical testing laboratory has so far executed 14 scout flotation tests on blended fluorspar ore samples from Monte Muambe, with products assay results pending the last 5 tests. Tests completed to date have allowed the Company to define a two-stages flotation pathway to reject silicates and oxides (first stage) and subsequently reject carbonates (second stage) in order to produce an acid grade fluorspar concentrate. The 5 tests with pending results are aimed at optimising the first stage parameters, which already show a very high selectivity against fluorite (with less than 2.1% CaF2 in the scout test no 6 tailings). As initially anticipated, gallium reports to the first stage tailings, resulting in a 100% gallium concentration increase in these tailings in relation to the run of mine. These results substantially de-risk the proposed process flowsheet by demonstrating that fluorite and gallium-bearing minerals respond differently during flotation.
Petards Group 10.25p £5.62m (PEG.L)*
The AIM quoted developer of advanced security, communication and surveillance systems this morning announced contract wins across Rail & Defence and QRO Solutions. QRO Solutions received purchase orders totalling £0.5m for the provision of ANPR equipment and support. Both orders are scheduled to be delivered during the current financial year. Petards Joyce-Loebl has received orders worth over £0.9m for its Rail and Defence systems. Rail first deliveries of the £500k contract are scheduled to be made later this year and the project is expected to be completed during 2027. The defence order of £400k is scheduled to be completed during 2026.
Vianet Group 68.00p £18.76m (VNET.L)
The international provider of actionable data, business insights and payment solutions updated on trading ahead of its AGM today. The Hospitality and Unattended Retail divisions delivered recurring revenue and gross profit growth during the Q1 compared with the prior year, with trading ahead of management's expectations. Group revenue for the first quarter grew by 3.1% year-on-year, with recurring revenue being 5.8% ahead representing approximately 88% of turnover - early evidence that the operational leverage built during FY26 is coming through. The Group's net cash position has strengthened further since the year end, standing at £0.7m on 30 June 2026.
AQSE Market:
IntelliAM 80.00 £15.68m (INT:AQSE) The provider of AI-driven software solutions for the manufacturing and engineering sectors announced that it has raised £500k through a combination of a c£220k placing at 70p per share and the issue of £280k unsecured convertible loan notes. The Issue Price represents a discount of 13 per cent. to the closing middle market price of 80 pence per ordinary share on 6 July. The proceeds are to support the growth of the Company's US operations, marketing around the launch of the new IntelliAM platform and general working capital. The Company reported unaudited FY26 pro forma revenue of approximately £5.25m, on 16 April, representing growth of approximately 35 per cent. year-on-year, and unaudited annual recurring revenue of approximately £1.65m, reflecting a doubling over the prior year and an increasingly predictable revenue base. The Board expects continued revenue growth of 20%+ in each of FY2027 and FY2028. The Company also proposes to enter into an Invoice Discounting Facility in the coming weeks to be able to manage the working capital of the business as the business grows.
What’s baking in the oven?
Potential IPOs:***
Dual List:***
Bravura Solutions (ASX: BVS) the global provider of enterprise software for the wealth management and funds administration industries has announced its intention to dual list on AIM. Bravura is currently listed on the Australian Securities Exchange (ASX) and Admission to AIM is being sought via the AIM Designated Market Route. No capital to be raised on Admission with a market cap on Admission of circa £500m. Expected Admission date is 28 July.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
